Mereo BioPharma (MREO) Net Shares Issued and Repurchased (2022 - 2026)

Mereo BioPharma (MREO) has reported Net Shares Issued and Repurchased for 5 consecutive years, with $6.5 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased rose 177.01% year-over-year to $6.5 million in Q1 2026; TTM through Mar 2026 was $6.5 million, a 177.01% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, down 4.14% from the prior year.
• Net Shares Issued and Repurchased was $6.5 million for Q1 2026 at Mereo BioPharma, up from $2.4 million in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $6.5 million in Q1 2026 and troughed at $2.3 million in Q1 2025.
• A 5-year average of $3.7 million and a median of $2.5 million in 2024 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased slumped 48.66% in 2024 and jumped 177.01% in 2026, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at $4.8 million in 2022, then gained by 0.71% to $4.9 million in 2023, then sank by 48.66% to $2.5 million in 2024, then fell by 4.14% to $2.4 million in 2025, then surged by 169.43% to $6.5 million in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $6.5 million (Q1 2026), $2.4 million (Q4 2025), and $2.3 million (Q1 2025), per Business Quant data.